These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3289388)

  • 1. Replacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease.
    Schmidt EW; Rasche B; Ulmer WT; Konietzko N; Becker M; Fallise JP; Lorenz J; Ferlinz R
    Am J Med; 1988 Jun; 84(6A):63-9. PubMed ID: 3289388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous administration of alpha-1-proteinase inhibitor in patients of PiZ and PiM phenotype. Preliminary report.
    Moser KM; Smith RM; Spragg RG; Tisi GM
    Am J Med; 1988 Jun; 84(6A):70-4. PubMed ID: 3260074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of alpha-1-protease inhibitor deficiency.
    Hutchison DC
    Am J Med; 1988 Jun; 84(6A):3-12. PubMed ID: 3289386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
    Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.
    Gadek JE; Klein HG; Holland PV; Crystal RG
    J Clin Invest; 1981 Nov; 68(5):1158-65. PubMed ID: 7028785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitors in chronic obstructive pulmonary disease.
    Barnett TB; Gottovi D; Johnson AM
    Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.
    Smith RM; Traber LD; Traber DL; Spragg RG
    J Clin Invest; 1989 Oct; 84(4):1145-54. PubMed ID: 2794051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
    Hubbard RC; Crystal RG
    Am J Med; 1988 Jun; 84(6A):52-62. PubMed ID: 3289387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local increase of antiprotease and neutrophil elastase-alpha 1-proteinase inhibitor complexes in lung cancer.
    Marchandise FX; Mathieu B; Francis C; Sibille Y
    Eur Respir J; 1989 Jul; 2(7):623-9. PubMed ID: 2476329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction.
    Abboud RT; Rushton JM; Grzybowski S
    Am Rev Respir Dis; 1979 Jul; 120(1):31-40. PubMed ID: 313728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical efficacy and safety of a new, ready-to-use, liquid alpha-1-proteinase inhibitor, GLASSIA (alpha1-proteinase inhibitor (human), intravenous).
    Sandhaus RA; Stocks J; Rouhani FN; Brantly M; Strauss P
    COPD; 2014 Feb; 11(1):17-25. PubMed ID: 23822603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative biochemical efficacy analysis of an alpha
    Li Z; Franke RM; Morris D; Yel L
    Pulm Pharmacol Ther; 2022 Jun; 73-74():102124. PubMed ID: 35314325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1-proteinase inhibitor in inflammatory states of humans and laboratory animals.
    Cochrane CG
    Am J Med; 1988 Jun; 84(6A):75-9. PubMed ID: 3260075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal interaction of alpha 1-antitrypsin and leukocyte elastolytic activity in patients with chronic obstructive pulmonary disease.
    Martin WJ; Taylor JC
    Am Rev Respir Dis; 1979 Aug; 120(2):411-9. PubMed ID: 314251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.
    Campos MA; Runken MC; Davis AM; Johnson MP; Stone GA; Buikema AR
    Adv Ther; 2018 Apr; 35(4):467-481. PubMed ID: 29616482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Proteases and Alpha-1 Antitrypsin Augmentation Therapy.
    Strange C
    Respir Care; 2018 Jun; 63(6):690-698. PubMed ID: 29794204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and administration to dogs of aerosols of alpha-1-proteinase inhibitor.
    Smith RM; Spragg RG
    Am J Med; 1988 Jun; 84(6A):48-51. PubMed ID: 3260073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
    Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
    N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Substitution therapy with alpha-1-Pi in patients with alpha-1-Pi deficiency and progressive pulmonary edema].
    Konietzko N; Becker M; Schmidt EW; Rasche B; Ulmer WT; Ferlinz R; Lorenz J
    Dtsch Med Wochenschr; 1988 Mar; 113(10):369-73. PubMed ID: 3280283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.